@article{80807a538efe4cfe9cba108f00f776c9,
title = "Diabetes research and care through the ages",
abstract = "As has been well established, the Diabetes Care journal's most visible signature event is the Diabetes Care Symposium held each year during the American Diabetes Association's Scientific Sessions. Held this past year on 10 June 2017 in San Diego, California, at the 77th Scientific Sessions, this event has become one of the most attended sessions during the Scientific Sessions. Each year, in order to continue to have the symposium generate interest,we revise the format and content of this event. For this past year, our 6th annual symposium, I felt it was time to provide a comprehensive overview of our efforts in diabetes care to determine, first and foremost, how we arrived at our current state of management. I also felt the narrative needed to include the current status of management, especially with a focus toward cardiovascular disease, and finally, we wanted to ask what the future holds. Toward this goal, I asked four of the most noted experts in the world to provide their opinion on this topic. The symposium started with a very thoughtful presentation by Dr. Jay Skyler entitled {"}A Look Back as to HowWe Got Here.{"} Thatwas followed by two lectures on current concepts by Dr. Bernard Zinman entitled {"}Current Treatment Paradigms TodaydHow Well Are We Doing?{"} and by Dr. Matthew Riddle entitled {"}Evolving Concepts and Future Directions for CardiovascularOutcomes Trials.{"} The final lecture for the symposium was delivered by Dr. Ele Ferrannini and was entitled {"}What Does the Future Hold?{"} As always, a well-attended and well-received symposium is now the norm for our signature event and our efforts were rewarded by the enthusiasm of the attendees. This narrative summarizes the lectures held at the symposium.",
author = "Bernard Zinman and Skyler, {Jay S.} and Riddle, {Matthew C.} and Ele Ferrannini",
note = "Funding Information: tant for and has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Novo Nordisk, and Sanofi and has received grant support from Boehringer Ingelheim, Novo Nordisk, and AstraZeneca. J.S.S. has acted as an advisor to ADOCIA, AstraZeneca, BD Technologies, Boehringer Ingelheim, Dance Biopharm, Diavacs, Elcelyx Therapeutics, Eli Lilly and Company, Ideal Life, ImmunoMolecular Therapeutics, Intarcia Therapeutics, Intrexon, Merck Sharp & Dohme, Orgenesis, Sanofi, Servier, vTv Therapeutics, Valeritas, and Viacyte; has received research funding from Mesoblast and Viacyte; is a member of the board of directors of Dexcom, Moerae Matrix, and VasoPrep Surgical; and has equity in Dance Bio-pharm, Dexcom, Ideal Life, Intrexon, Moerae Matrix, and VasoPrep Surgical. M.C.R. has received honoraria for consulting from ADOCIA, Eleclyx, Sanofi, and Valeritas; for serving on a data safety monitoring committee for AstraZeneca and GlaxoSmithKline; for serving on a clinical trial steering committee for Eli Lilly and Company and Theracos; and for speaking at professional meetings for Sanofi and has received research support through his institution from AstraZeneca, Eli Lilly and Company, and Novo Nordisk. E.F. has been a speaker and consultant for AstraZeneca, Takeda, Novo Nordisk, Sanofi, Mitsubishi Tanabe, Eli Lilly and Company, Boehringer Ingelheim, and Merck Sharp & Dohme; has received research funds from Boehringer Ingelheim and Eli Lilly and Company; has done ad hoc consulting for Janssen and AstraZeneca; and is a member of the scientific advisory board of Boehringer Ingelheim/Eli Lilly and Company, Merck Sharp & Dohme, and Sanofi. Prior Presentation. Parts of this article were presented at the 77th Scientific Sessions of the American Diabetes Association, San Diego, CA, 10 June 2017. Publisher Copyright: {\textcopyright} 2017 by the American Diabetes Association.",
year = "2017",
month = oct,
day = "1",
doi = "10.2337/dci17-0042",
language = "English (US)",
volume = "40",
pages = "1302--1313",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "10",
}